Price T Rowe Associates Inc
recently revealed that they own a 10% stake in Stericycle Inc (NASDAQ:SRCL) in a Form 13G/A disclosure that was filed with the Securities and Exchange Commission on Monday, March 12th. The investor owns 8,570,548 shares of the stock valued at approximately $556,142,860. The disclosure is available through EDGAR at this hyperlink.
A number of research analysts have commented on the company. Barrington Research reaffirmed a “buy” rating on shares of Stericycle in a report on Monday, February 26th. BMO Capital Markets reaffirmed a “market perform” rating and issued a $64.00 price objective (down from $72.00) on shares of Stericycle in a report on Friday, February 23rd. Royal Bank of Canada decreased their price objective on Stericycle from $75.00 to $61.00 and set an “underperform” rating on the stock in a report on Thursday, February 22nd. Robert W. Baird raised Stericycle from an “underperform” rating to a “neutral” rating and set a $73.00 price objective on the stock in a report on Tuesday, February 13th. Finally, BidaskClub raised Stericycle from a “sell” rating to a “hold” rating in a report on Wednesday, January 31st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company. Stericycle presently has a consensus rating of “Hold” and a consensus target price of $70.67.
Stericycle Inc (NASDAQ SRCL) traded up $0.22 during trading hours on Monday, hitting $64.89. The stock had a trading volume of 55,271 shares, compared to its average volume of 1,085,722. The company has a market cap of $5,532.15, a P/E ratio of 14.90, a price-to-earnings-growth ratio of 1.47 and a beta of 0.42. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.90. Stericycle Inc has a 1 year low of $58.53 and a 1 year high of $88.00.
Stericycle (NASDAQ:SRCL) last released its earnings results on Wednesday, February 21st. The business services provider reported $1.00 earnings per share for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.14). The company had revenue of $887.80 million for the quarter, compared to the consensus estimate of $882.62 million. Stericycle had a net margin of 1.18% and a return on equity of 13.83%. The business’s revenue was down 2.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 earnings per share. analysts expect that Stericycle Inc will post 4.58 EPS for the current fiscal year.
In related news, Director Jack W. Schuler bought 10,000 shares of the business’s stock in a transaction dated Thursday, March 1st. The stock was purchased at an average cost of $62.59 per share, for a total transaction of $625,900.00. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 3.50% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.